Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532154 | NSE Symbol : | ISIN : INE560F01022 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
21-Jan-2025	31-Jan-2025	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements ) Regul ations 2015 we would like to inform you t hat a meeting of the Board of Directors of the Company will be held on Friday 31st January 2025 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Friday 31st January 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024. The board meeting commented at 06:25 PM and concluded at 06:45 PM Please take the above intimation in your records. Thanking You, PFA (As per BSE Announcement Dated on 31/01/2025)
22-Jan-2025	22-Jan-2025	Change in Registered Address	PFA
15-Oct-2024	13-Nov-2024	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve PFA Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of t he SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Wednesday 13th November 2024 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September, 2024. The meeting commenced at 06:15 P.M. and concluded at 06.40P.M. Kindly take the same on your record and oblige. Thanking You (As per BSE Announcement Dated on 13/11/2024)
25-Jul-2024	01-Aug-2024	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2024. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. PFA (As per BSE Announcement Dated on 01/08/2024)
16-May-2024	25-May-2024	Accounts	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Saturday 25th May 2024 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results ofthe Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. Audited Financial Results for the Quarter and Year ended on 31st March, 2024 Outcome of the Board Meeting held on 25th May 2024. (As Per BSE Announcement Dated on 25/05/2024)
16-Jan-2024	22-Jan-2024	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday January 22 2024 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Monday 22nd January 2024 . 1.) Considered and approved Un-audited financial results for the quarter ended as on 31st December 2023. The meeting commenced at 05.10 P.M. and concluded at 05.40 P.M. Kindly take the same on your record and oblige. Thanking You PFA (As per BSE Announcement Dated on 22/01/2024)
26-Oct-2023	01-Nov-2023	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday November 1 2023inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2023 and also transact other business activities. Please take the above intimation in your records. Thanking you.
03-Aug-2023	10-Aug-2023	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 10th August 2023 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Thursday 10th August 2023 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2023. The board meeting concluded on 06.30 P.M. Please take the above intimation in your records. Thanking You, (As per BSE Announcement Dated on 10/08/2023)
18-May-2023	24-May-2023	Accounts	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 24th May 2023 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2023. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. This is to inform you that Outcome of the Board Meeting of the Company held on Wednesday 24th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 04.00 P.M (As Per BSE Announcement dated on 24.05.2023)
27-Jan-2023	02-Feb-2023	Quarterly Results	Quarterly Results Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday February 02, 2023 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2022 also transact other business activities. Please take the above intimation in your records. Thanking You. (As per BSE Announcement Dated on 27/01/2023) In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2022 and board meeting concluded on 5.30 P.M. Kindly take the same on your record and oblige. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2022 and board meeting concluded on 5.30 P.M. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement dated on 02.02.2023)
03-Nov-2022	09-Nov-2022	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday November 09 2022 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2022 and also transact other business activities. Please take the above intimation in your records. Thanking you In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2022. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated on 09/11/2022)
07-Jul-2022	25-Jul-2022	Quarterly Results	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 inter alia to consider and approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022. Any other matter with the permission of the board which the Board may think fit. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday July 25, 2022 at the Registered Office of the Company and transacted the following major businesses: 1. Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2022. Thanking You. (As per BSE Announcement Dated on 25/07/2022)
19-May-2022	25-May-2022	Accounts	Audited Results Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 25th May, 2022 at registered office of the company inter alia, to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2022. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. This is to inform you that Outcome of the Board Meeting of the Company held on Wednesday 25th May 2022 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2022. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2022. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2022 with unmodified opinion. Request you to kindly take on record the same. Thanking You. (As Per BSE Announcement Dated on 25.05.2022)
09-Apr-2022	09-Apr-2022	Bonus Issue	Apropos the captioned subject please be informed that the Board of Directors have in the allotment meeting held on April 9, 2022 allotted 5,00,00,000 bonus equity shares to the shareholders entitled for these shares subsequently increasing the paid up and issued capital of the Company from Rs. 50,00,00,000/-(divided into 50,00,00,000 equity shares of the face value of Rs.1/-each) to Rs. 55,00,00,000/-(divided into 55,00,00,000 equity shares of the face value of Rs.1/-each). We further wish to inform that the said 5,00,00,000 bonus shares will be credited to the account of respective shareholders on or before April 19,2022. This is for your information and records pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you.
17-Jan-2022	18-Feb-2022	Bonus Issue	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2022 inter alia to consider and approve issue of Bonus Shares to the equity shareholders of the company. Inter alia, have approved and recommended the issuance of fully paid up Bonus Shares in the ratio of 1:10 (i.e. 1 (One) fully paid up equity share for every 10 (Ten) fully paid up equity share held, subject to the shareholders' approval through Postal Ballot. (As Per BSE Bulletin Dated on 18.02.2022)

1 2

LOGIN HERE

Johnson Pharmacare Ltd

Board Meeting